TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Silence Therapeutics at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Silence Therapeutics takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions cover siRNA design and an obesity application. It revisits end stabilization to extend siRNA duration of action through nuclease resistance, and presents SLN098, an siRNA that silences the genetically validated target INHBE to enhance fat loss while preserving lean mass.

OrganizationTIDES Europe 2026 Attendance
Silence Therapeutics
London, United Kingdom
Biotech
Develops siRNA medicines using its mRNAi GOLD platform for cardiovascular, haematological and other diseases.
Talk
Wed Nov 4
10:15–10:45
Elongating siRNA Duration of Action by Enhanced Nuclease Resistance: End Stabilization Revisited
A modification near each end of a siRNA made gene silencing in mice last longer while needing fewer sulfur linkages.
Talk
Fri Nov 6
11:15–11:40
Presentation: Genetically-Validated INHBE Silencing with SLN098 siRNA for Enhanced Fat Loss and Lean Mass Preservation
Post-event symposium: Clinical & Translational Updates

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Silence Therapeutics

Tell us what you sell and we’ll find the people at Silence Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction